Leuprorelin acetate Prescribing at MONTGOMERY HOUSE SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
167
Total Quantity
179
NHS Cost
£31.6K
vs National Avg
+260.4%
MONTGOMERY HOUSE SURGERY prescribed 167 items of Leuprorelin acetate over the last 12 months at a cost of £31,609 to the NHS. This is 260.4% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
16
Jul 2026
18
Jul 2026
9
Jul 2026
8
Jul 2026
13
Jul 2026
8
Jul 2026
13
Jul 2026
12
Jul 2026
14
Jul 2026
12
Jul 2026
24
Jul 2026
20
Prescribing Details
| Total Items | 167 |
|---|---|
| Total Quantity | 179 |
| Total NHS Cost | £31,609 |
| Presentations | 6 different forms |
| vs National Average | +260.4% |
Leuprorelin acetate Prescribing Comparison
| This practice | 167 items |
|---|---|
| National average per practice | 46 items |
| Difference | +260.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.